NCT00721474

Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

An Open-Label, Randomized, Single-Dose, 2-Period Crossover Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A Study to determine if a high-fat meal has an effect on the pharmacokinetics of bosutinib.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	Bosutinib	Bosutinib fasting
DRUG	Bosutinib	Bosutinib fed

Timeline

• Start date: 2008-09-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2008-07-24
• Last updated: 2009-02-06

Locations

1 site across 1 country: United States